News

A joint proposition connecting upstream metabolic modelling with downstream process optimisation, TEA, and LCA — so teams can make better decisions from cell to product. New Wave Biotech is pleased to announce a strategic partnership with iMEAN, bringing together two complementary areas of expertise to help biomanufacturers make better process decisions across the full bioprocess. By connecting iMEAN's upstream metabolic modelling and strain design capabilities with New Wave

New Wave Biotech has partnered with Nurasa to accelerate the scale-up of sustainable food and ingredient innovations. By combining New Wave Biotech’s AI-driven bioprocess simulation software with Nurasa’s physical scale-up infrastructure and commercialisation ecosystem, innovators gain early insight into cost, yield and sustainability—reducing risk and speeding the path from R&D to market-ready production across food and biomanufacturing

New Wave Biotech, an innovator in bioprocess optimisation,  has launched the industry’s first biotech-specific Life Cycle Assessment (LCA) solution. Fully integrated into its AI-powered process simulation platform, the new capability allows biomanufacturers to quantify and compare the environmental impact of their processes, from climate change and energy output to land and water use, while simultaneously optimising for cost and performance.

Manchester, 7 October 2025  – New Wave Biotech has announced a partnership with CPI, th e UK’s national translational research and innovat ion organization, to address one of industrial biotechnology’s most persistent hurdles – lipid extraction. The collaboration will combine CPI’s downstream processing expertise with New Wave Biotech’s hybrid AI-powered simulation platform to optimize solvent and non-solvent extraction methods, aiming to enhance scalability, cost efficiency,

New whitepaper outlines how Lean Startup principles can accelerate food tech innovation Singapore & London – 24 April 2025  – What...

According to McKinsey, synthetic biology could be worth up to $4 trillion a year over the next ten to 20 years,  with use cases ranging...

AI bioprocess simulation software company New Wave Biotech has raised €1.2 million in its latest funding round through a mix of equity and g

AI bioprocess simulation platform empowers biomanufacturers to make better decisions and processing tech companies to accelerate sales...

We are delighted to announce that New Wave Biotech has been selected to join the 2024 EIT Food Accelerator Network programme from over...

UK Research and Innovation  has launched a pioneering Engineering Biology R&D initiative to boosting synthetic biology's potential to...

Innovate UK-backed partnership harnesses AI to scale cultivated meat quicker, better and at lower cost  London, 13th December 2023  - AI...

We are thrilled to announce that we've been selected to join Big Idea Ventures  Accelerator and join the community of so many pioneering...

New Wave Biotech is proud to announce that we have been awarded an Innovate UK  Transformative Technology Grant. At New Wave Biotech, our...

We're thrilled to be selected for the Royal Society of Chemistry 's Emerging Tech Competition finals!

We are delighted to announce that we've been selected as a finalist of the Best Investment in Diversity & Deep Tech at UK Business Angels...

New Wave Biotech will be joining Innovate UK Advanced Manufacturing Global Incubator Programme  in Singapore, run by Singapore Deep-Tech...